Clinical trial
Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months…
NCT00404651 · Sanofi Pasteur, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00404651 |
|---|---|
| Title | Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Infants |
| Official title | Lot to Lot Consistency Study of DTaP-IPV-Hep B-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy Mexican Infants |
| Lead sponsor | Sanofi Pasteur, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis |
| Intervention type | Biological |
| Interventions | DTaP-IPV-HB-PRP~T vaccine, DTaP-HBV-IPV vaccine |
| Enrollment | 1,189 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Nov 29, 2006 |
| Last update posted | May 9, 2014 |
| Countries | Mexico |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: